John P. McLaughlin
2013
In 2013, John P. McLaughlin earned a total compensation of $2.9M as President and Chief Executive Officer at PDL BioPharma, a 14% increase compared to previous year.
Compensation breakdown
| Bonus | $469,000 |
|---|---|
| Non-Equity Incentive Plan | $1,511,875 |
| Salary | $695,250 |
| Stock Awards | $201,000 |
| Other | $10,000 |
| Total | $2,887,125 |
McLaughlin received $1.5M in non-equity incentive plan, accounting for 52% of the total pay in 2013.
McLaughlin also received $469K in bonus, $695.3K in salary, $201K in stock awards and $10K in other compensation.
Rankings
In 2013, John P. McLaughlin's compensation ranked 2,638th out of 12,286 executives tracked by ExecPay. In other words, McLaughlin earned more than 78.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,638 out of 12,286 | 79th |
Division Manufacturing | 876 out of 4,612 | 81st |
Major group Chemicals And Allied Products | 232 out of 1,466 | 84th |
Industry group Drugs | 155 out of 1,160 | 87th |
Industry Biological Products, Except Diagnostic Substances | 21 out of 200 | 90th |
Source: SEC filing on April 20, 2016.
McLaughlin's colleagues
We found five more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2013.
2013
Christopher Stone
PDL BioPharma
General Counsel
2013
Danny Hart
PDL BioPharma
Vice President, Business Development
2013
Peter Garcia
PDL BioPharma
Chief Financial Officer
2013
David Montez
PDL BioPharma
Chief Accounting Officer
2013
Caroline Krumel
PDL BioPharma